Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,234,881
-$1,671,792 QoQ
Shares Held
644,514
-26.9% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#123
of 1,020 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $463,988,771 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,252,140 | $305,558,778 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,356,009 | $45,941,583 | |
| 3 | HLN |
Haleon plc
|
3,095,451 | $28,880,557 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,674,005 | $26,834,300 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
707,194 | $17,404,044 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
29,023 | $15,725,531 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
69,482 | $11,710,496 | |
| 8 | VTRS |
Viatris Inc
This page
|
644,514 | $10,234,881 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,234,881 | 644,514 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,906,673 | 881,323 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,409,332 | 836,091 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,902,698 | 394,212 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,504,523 | 504,426 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,320,153 | 1,873,726 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,593,037 | 1,011,489 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $13,591,013 | 1,170,630 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $10,783,379 | 1,014,429 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $11,548,068 | 967,175 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $13,530,676 | 1,249,370 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $17,003,953 | 1,724,539 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $17,776,395 | 1,781,202 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $11,945,788 | 1,241,766 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $25,575,681 | 2,297,905 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $17,019,227 | 1,997,562 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $24,051,390 | 2,297,172 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $17,168,607 | 1,577,997 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $17,525,827 | 1,295,331 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $14,038,422 | 1,036,046 | Shares | Defined | 2021-11-03 | |
| 2021-06-30 | $9,894,452 | 692,404 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $10,382,098 | 743,171 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $12,157,331 | 648,737 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||